Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunoinformatic Approach to the Design of a Novel Multi-Epitope Vaccine Against Leishmania Major Fused to Human Igg-Fc Publisher



Fadaie M1 ; Shahmoradi Z2 ; Khanahmad H1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Skin Diseases and Leishmaniasis Research Center, Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Research in Pharmaceutical Sciences Published:2024


Abstract

Background and purpose: Cutaneous leishmaniasis poses significant health and socioeconomic challenges, making vaccine development a top priority, especially in endemic regions. Cysteine proteases, KMP-11, and HASPB proteins are promising candidates for leishmaniasis vaccine development owing to their immunogenic properties and capacity to provoke robust immune responses, as evidenced by different investigations. This study aimed to design a recombinant chimeric protein (MEV-Fc) vaccine using multi-epitopes from these Leishmania major proteins. Experimental approach: The antigens were subjected to immunoinformatic prediction and screening of HTL, CTL, and B-cell epitopes. The multi-epitope protein was designed with significantly high-scoring epitopes and suitable linkers. Natural adjuvants were then added to enhance immunogenicity. Vaccine potency was innovatively improved by covalently fusing human IgG1 Fc with multi-epitope protein. To investigate how the MEV-Fc vaccine interacts with Toll-like receptors, molecular docking, multi-scale normal mode analysis simulation, and computational immune simulation were employed to study humoral and cellular immune responses. Findings/Results: The results demonstrated the vaccine's antigenicity, stability, and nontoxicity. The structural validation confirmed the accuracy of the 3D models, indicating robust interactions with TLR2 and TLR4, with binding free energies of -1269.9 and -1128.7 (kcal/mol), respectively. Immune simulation results showed significant increases in IgM and IgG antibody levels following three vaccinations, along with enhanced activation of B cells, helper T cells, and cytotoxic T lymphocytes. Conclusion and implications: These findings provide novel insights for developing effective candidates for cutaneous leishmaniasis vaccines. However, laboratory experiments are necessary to evaluate its protective effects. © 2024 Research in Pharmaceutical Sciences.
Related Docs
View other Related Docs
1. Engineering a Multi-Epitope Vaccine Candidate Against Leishmania Infantum Using Comprehensive Immunoinformatics Methods, Biologia (2022)
2. Bioinformatics Analysis for the Purpose of Designing a Novel Multi-Epitope Dna Vaccine Against Leishmania Major, Scientific Reports (2022)
3. Bioinformatics Design of a Peptide Vaccine Containing Sarcoma Antigen Ny-Sar-35 Epitopes Against Breast Cancer and Evaluation of Its Immunological Function in Balb/C Mouse Model, PLoS ONE (2024)
4. Development of a Chimeric Vaccine Candidate Based on Toxoplasma Gondii Major Surface Antigen 1 and Apicoplast Proteins Using Comprehensive Immunoinformatics Approaches, European Journal of Pharmaceutical Sciences (2021)
5. Evaluation of Humoral and Cellular Immune Responses Against Vibrio Cholerae Using Oral Immunization by Multi-Epitope-Phage-Based Vaccine, International Immunopharmacology (2024)
6. Computational Clues of Immunogenic Hotspots in Plasmodium Falciparum Erythrocytic Stage Vaccine Candidate Antigens: In Silico Approach, BioMed Research International (2022)
7. Multi-Epitope Vaccine Against Cystic Echinococcosis Using Immunodominant Epitopes From Ega31 and Egg1y162 Antigens, Informatics in Medicine Unlocked (2020)
8. In-Silico Design of a New Multi-Epitope Vaccine Candidate Against Sars-Cov-2, Acta Virologica (2023)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Hejazi (33)
Hossein Khanahmad (13)
Other Related Docs
9. Development of Polyepitopic Immunogenic Contrast Against Hepatitis C Virus 1A-6A Genotype by in Silico Approach, Biomedical and Biotechnology Research Journal (2020)
10. A Lentiviral Vaccine Expressing Kmp11-Haspb Fusion Protein Increases Immune Response to Leishmania Major in Balb/C, Parasitology Research (2018)
11. Evaluation of a Novel Lentiviral Vaccine Expressing Kmp11-Haspb Fusion Protein Against Leishmania Infantum in Balb/C Mice, Parasite Immunology (2016)
12. Exploring the Cancer-Testis Antigen Boris to Design a Novel Multi-Epitope Vaccine Against Breast Cancer Based on Immunoinformatics Approaches, Journal of Biomolecular Structure and Dynamics (2022)
13. Leishmania Vaccines Entered in Clinical Trials: A Review of Literature, International Journal of Preventive Medicine (2019)
14. Toxoplasma Gondii Tyrosine-Rich Oocyst Wall Protein: A Closer Look Through an in Silico Prism, BioMed Research International (2021)
15. Design of Multivalent-Epitope Vaccine Models Directed Toward the World’S Population Against Hiv-Gag Polyprotein: Reverse Vaccinology and Immunoinformatics, PLoS ONE (2024)
16. Exploring the Out of Sight Antigens of Sars-Cov-2 to Design a Candidate Multi-Epitope Vaccine by Utilizing Immunoinformatics Approaches, Vaccine (2020)
17. Designing a Multi-Epitope Influenza Vaccine: An Immunoinformatics Approach, Scientific Reports (2024)
18. Novel Sars-Cov2 Poly Epitope Phage-Based Candidate Vaccine and Its Immunogenicity, Research in Pharmaceutical Sciences (2024)
19. In Silico Analysis of Transmembrane Protein 31 (Tmem31)Antigen to Design Novel Multiepitope Peptide and Dna Cancer Vaccines Against Melanoma, Molecular Immunology (2019)
20. Insights Into the Biochemical Features and Immunogenic Epitopes of Common Bradyzoite Markers of the Ubiquitous Toxoplasma Gondii, Infection, Genetics and Evolution (2021)
21. Comparison of Protein Profile of Killed and Autoclaved Leishmania Major Using Polyacrylamide Gel Electrophoresis, Journal of Isfahan Medical School (2013)
22. From Classical Approaches to New Developments in Genetic Engineering of Live Attenuated Vaccine Against Cutaneous Leishmaniasis: Potential and Immunization, Frontiers in Public Health (2024)
23. Induction of Immune Responses by Dna Vaccines Formulated With Dendrimer and Poly (Methyl Methacrylate) (Pmma) Nano-Adjuvants in Balb/C Mice Infected With Leishmania Major, Open Access Macedonian Journal of Medical Sciences (2018)
24. The Comparison of the Ifn-ɤ, Tnf-Α and Il-10 Cytokines in Healing and Non-Healing Cutaneous Leishmaniasis, Iranian Journal of Parasitology (2021)
25. Evaluation of Live Recombinant Nonpathogenic Leishmania Tarentolae Expressing Cysteine Proteinase and A2 Genes As a Candidate Vaccine Against Experimental Canine Visceral Leishmaniasis, PLoS ONE (2015)
26. Immunoinformatic Analysis of Calcium-Dependent Protein Kinase 7 (Cdpk7) Showed Potential Targets for Toxoplasma Gondii Vaccine, Journal of Parasitology Research (2021)
27. Exposure to Leishmania Major Modulates the Proportion of Cd4+ T Cells Without Affecting Cellular Immune Responses, Microbiology and Immunology (2007)
28. Vaccination in Leishmaniasis: A Review Article, Iranian Biomedical Journal (2022)
29. Interleukin-10 and Transforming Growth Factor-Β in Early and Late Lesions of Patients With Leishmania Major Induced Cutaneous Leishmaniasis, Iranian Journal of Parasitology (2012)
30. Combinatorial Delivery of Antigen and Tlr Agonists Via Plga Nanoparticles Modulates Leishmania Major-Infected-Macrophages Activation, Biomedicine and Pharmacotherapy (2021)
31. Nramp1 Gene Polymorphisms and Cutaneous Leishmaniasis: An Evaluation on Host Susceptibility and Treatment Outcome, Journal of Vector Borne Diseases (2016)
32. In Silico and in Vivo Studies of Truncated Forms of Flagellin (Flic) of Enteroaggregative Escherichia Coli Fused to Fimh From Uropathogenic Escherichia Coli As a Vaccine Candidate Against Urinary Tract Infections, Journal of Biotechnology (2014)
33. Immunoinformatics Design and Synthesis of a Multi-Epitope Vaccine Against Helicobacter Pylori Based on Lipid Nanoparticles, Scientific Reports (2024)
34. Locked Nucleic Acid -Anti- Let-7A Induces Apoptosis and Necrosis in Macrophages Infected With Leishmania Major, Microbial Pathogenesis (2018)
35. Study of Therapeutic Effect of Different Concentrations of Imatinib on Balb/C Model of Cutaneous Leishmaniasis, AIMS Microbiology (2020)
36. Anti-Leishmaniasis Effect of Staphylococcus Aureus Protein a on the Size of the Lesion and Parasitic Load, Advanced Biomedical Research (2023)
37. Immunological Comparison of Dna Vaccination Using Two Delivery Systems Against Canine Leishmaniasis, Veterinary Parasitology (2015)
38. Regulatory T-Cell Profile in Early and Late Lesions of Cutaneous Leishmaniasis Due to Leishmania Major, Journal of Research in Medical Sciences (2012)
39. In Silico Design of Discontinuous Peptides Representative of B and T-Cell Epitopes From Her2-Ecd As Potential Novel Cancer Peptide Vaccines, Asian Pacific Journal of Cancer Prevention (2013)
40. Designing a Chimeric Subunit Vaccine for Influenza Virus, Based on Ha2, M2e and Ctxb: A Bioinformatics Study, BMC Molecular and Cell Biology (2020)
41. Evaluation of the Anti-Leishmanial Effect of Recombinant Clostridium Α-Toxin, Infection and Drug Resistance (2020)
42. Functional and Structural Characterization of Ebola Virus Glycoprotein (1976-2015)-An in Silico Study, International Journal of Biomathematics (2017)
43. Immune Response Measured in Human Volunteers Vaccinated With Autoclaved Leishmania Major Vaccine Mixed With Low Dose of Bcg, Clinical and Experimental Immunology (2003)
44. Randomised Vaccine Trial of Single Dose of Killed Leishmania Major Plus Bcg Against Anthroponotic Cutaneous Leishmaniasis in Bam, Iran, Lancet (1998)
45. The Role of Metacaspases and Other Proteins Involved in the Apoptosis of Leishmania: Review Article, Iranian Journal of Parasitology (2025)
46. Comparison of Pro-Inflammatory Cytokines of Non-Healing and Healing Cutaneous Leishmaniasis, Scandinavian Journal of Immunology (2017)
47. Comparison of Immune Regulatory Factors in Acute and Chronic Lesions of Cutaneous Leishmaniasis Due to Leishmania Major, Journal of Research in Medical Sciences (2014)
48. Cloning, Expression and Dynamic Simulation of Tryp6 From Leishmania Major (Mrho/Ir/75/Er), Molecular Biology Reports (2011)
49. Effect of Leishmania Gerbilli Injection on Mice Immunization Against Cutaneous Leishmaniasis (Cl) Caused by Leishmania Major, Pakistan Journal of Biological Sciences (2007)
50. Tlr2 and Tlr4 in Cutaneous Leishmaniasis Caused by Leishmania Major, Scandinavian Journal of Immunology (2013)